ストックスクリーナーアプリを入手
62.00
7.45%
4.30
アフターアワーズ：
60.99
-1.01
-1.63%
Mbx Biosciences Inc (MBX) 最新ニュース
MBX Biosciences stock hits all-time high at 59.55 USD By Investing.com - Investing.com South Africa
MBX Biosciences on Track for Record High Close -- Data Talk - Moomoo
MBX Biosciences: Weekly PTH, Monthly Obesity, Multi-Year Upside (Initiating Buy) - Seeking Alpha
Price to earnings forward of MBX Biosciences, Inc. – NASDAQ:MBX - TradingView
MBXMBX Biosciences Inc Options - Finviz
Paradigm Biocapital Advisors LP Acquires Significant Stake in MB - GuruFocus
MBX Biosciences Soars on Breakthrough Trial Momentum - TipRanks
Mbx biosciences stock hits all-time high of 54.98 USD - Investing.com
Mbx biosciences stock hits all-time high of 54.98 USD By Investing.com - Investing.com India
MBX Biosciences, Inc.(NasdaqGS:MBX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) dropped from Russell 2000 Value Benchmark - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS:MBX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) added to Russell 2000 Growth Benchmark - marketscreener.com
Does MBX (MBX) Joining Russell Growth Indexes Mark a Lasting Shift in Its Market Narrative? - simplywall.st
MBX Biosciences, Inc.(NasdaqGS: MBX) added to Russell 3000E Growth Benchmark - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) added to Russell 2500 Growth Benchmark - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) dropped from Russell 3000 Value Benchmark - marketscreener.com
MBX Biosciences, Inc. Actuals & Estimates (NASDAQ:MBX) - TradingView
MBX Biosciences Rises After Positive Clinical Trial Update - TipRanks
MBX Forecast — Price Target — Prediction for 2027 - TradingView
MBX Biosciences Inc (MBX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Paradigm entities disclose multi-million share stakes in MBX (MBX) - Stock Titan
MBX Biosciences highlights sustained calcium control in rare disease - MSN
MBX Biosciences Soars on Breakthrough Trial Results - TipRanks
Mbx Biosciences stock hits all-time high at 45.88 USD By Investing.com - Investing.com Australia
Mbx Biosciences stock hits all-time high at 45.88 USD - Investing.com
MBX Biosciences shares fall despite positive one-year trial results for Canvuparatide (MBX) - MSN
MBX Biosciences Inc (MBX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MBX Biosciences Inc (MBX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MBX Biosciences Inc (MBX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Analyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity - TipRanks
MBX Biosciences Inc (MBX) Valuation: PE, PB & Fair Value Analysis - TradingKey
MBX Biosciences Inc (MBX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MBX Biosciences Inc (MBX) Institutional Confidence - TradingKey
MBX Biosciences Inc (MBX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MBX Biosciences Inc (MBX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MBX News | MBX BIOSCIENCES INC (NASDAQ:MBX) - ChartMill
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and Alnylam Pharma (ALNY) - The Globe and Mail
MBX updates data from mid-stage trial for endocrine disease therapy - MSN
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Pfizer (PFE) and MBX Biosciences, Inc. (MBX) - The Globe and Mail
How Do MBX Biosciences’ (MBX) Phase 2 Results Reframe Its Long-Term Hypoparathyroidism Strategy? - Yahoo! Finance Canada
Guggenheim Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $88 - Moomoo
Barclays Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $70 - Moomoo
MBX's Flagship Drug Trial Met Expectations But Perhaps Some Investors Wanted More -- Market Talk - Moomoo
MBX Biosciences (MBX) Slips 4.67% as Stock Tests Key Support LevelsHagopian Line - dars.gov.et
Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Health Care Roundup: Market Talk - Moomoo
LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $91 - Moomoo
MBX Biosciences, Inc. Common Stock (NASDAQ: MBX) Share Price, MBX Stock News, MBX Share Price & Updates - Kalkine
Mbx Biosciences90% of Patients in Ole Rema - Moomoo
Street canvu MBX phase II HP data more than one way - BioWorld News
1.18%
2.48%
大文字化:
|
ボリューム (24 時間):